Atlas Trials

Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs

Clinical trial NCT00002240 · COMPLETED

Trial details

NCT number
NCT00002240
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV Infections
Start date
1999-03-01
Primary completion
2001-12-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.